Literature DB >> 23017533

Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial.

Simon Stewart1, Melinda J Carrington, Thomas H Marwick, Patricia M Davidson, Peter Macdonald, John D Horowitz, Henry Krum, Phillip J Newton, Christopher Reid, Yih Kai Chan, Paul A Scuffham.   

Abstract

OBJECTIVES: The goal of this study was to make a head-to-head comparison of 2 common forms of multidisciplinary chronic heart failure (CHF) management.
BACKGROUND: Although direct patient contact appears to be best in delivering CHF management overall, the precise form to optimize health outcomes is less clear.
METHODS: This prospective, multicenter randomized controlled trial with blinded endpoint adjudication comprised 280 hospitalized CHF patients (73% male, age 71 ± 14 years, and 73% with left ventricular ejection fraction ≤45%) randomized to home-based intervention (HBI) or specialized CHF clinic-based intervention (CBI). The primary endpoint was all-cause, unplanned hospitalization or death during 12- to 18-month follow-up. Secondary endpoints included type/duration of hospitalization and healthcare costs.
RESULTS: The primary endpoint occurred in 102 of 143 (71%) HBI versus 104 of 137 (76%) CBI patients (adjusted hazard ratio [HR]: 0.97 [95% confidence interval (CI): 0.73 to 1.30], p = 0.861): 96 (67.1%) HBI versus 95 (69.3%) CBI patients had an unplanned hospitalization (p = 0.887), and 31 (21.7%) versus 38 (27.7%) died (p = 0.252). The median duration of each unplanned hospitalization was significantly less in the HBI group (4.0 [interquartile range (IQR): 2.0 to 7.0] days vs. 6.0 [IQR: 3.5 to 13] days; p = 0.004). Overall, 75% of all hospitalization was attributable to 64 (22.9%) patients, of whom 43 (67%) were CBI patients (adjusted odds ratio: 2.55 [95% CI: 1.37 to 4.73], p = 0.003). HBI was associated with significantly fewer days of all-cause hospitalization (-35%; p = 0.003) and from cardiovascular causes (-37%; p = 0.025) but not for CHF (-24%; p = 0.218). Consequently, healthcare costs ($AU3.93 vs. $AU5.53 million) were significantly less for the HBI group (median: $AU34 [IQR: 13 to 81] per day vs. $AU52 [17 to 140] per day; p = 0.030).
CONCLUSIONS: HBI was not superior to CBI in reducing all-cause death or hospitalization. However, HBI was associated with significantly lower healthcare costs, attributable to fewer days of hospitalization. (Which Heart failure Intervention is most Cost-effective & consumer friendly in reducing Hospital care [WHICH?]; ACTRN12607000069459).
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23017533     DOI: 10.1016/j.jacc.2012.06.025

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  42 in total

Review 1.  Have Traditional Heart Failure Management Programs Reached Their "Use by" Date? Time to Apply More Nuanced Care.

Authors:  Simon Stewart
Journal:  Curr Heart Fail Rep       Date:  2019-06

2.  Heart failure. Optimal postdischarge management of chronic HF.

Authors:  Simonetta Scalvini; Amerigo Giordano
Journal:  Nat Rev Cardiol       Date:  2012-11-20       Impact factor: 32.419

Review 3.  What is the optimal place for heart failure treatment and care: home or hospital?

Authors:  Simon Stewart
Journal:  Curr Heart Fail Rep       Date:  2013-09

4.  Evaluation of a Community Health Service Center-Based Intervention Program for Managing Chronic Heart Failure.

Authors:  Moli Gu; Yanlan Ma; Ti Zhou; Yunfeng Xia
Journal:  Balkan Med J       Date:  2016-01-01       Impact factor: 2.021

5.  Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice.

Authors:  Hung-I Lu; Tien-Hung Huang; Pei-Hsun Sung; Yung-Lung Chen; Sarah Chua; Han-Yan Chai; Sheng-Ying Chung; Chu-Feng Liu; Cheuk-Kwan Sun; Hsueh-Wen Chang; Yen-Yi Zhen; Fan-Yen Lee; Hon-Kan Yip
Journal:  Acta Pharmacol Sin       Date:  2016-04-11       Impact factor: 6.150

6.  Applying Heart Failure Management to Improve Health Outcomes: But WHICH One?

Authors:  Yih-Kai Chan; Alice M David; Caitlyn Mainland; Lei Chen; Simon Stewart
Journal:  Card Fail Rev       Date:  2017-11

Review 7.  Setting Up a Heart Failure Program in 2018: Moving Towards New Paradigm(s).

Authors:  Nadia Bouabdallaoui; Anique Ducharme
Journal:  Curr Heart Fail Rep       Date:  2018-12

Review 8.  In-home care for optimizing chronic disease management in the community: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2013-09-01

9.  Cognitive Function in Cardiac Patients: Exploring the Occupational Therapy Role in Lifestyle Medicine.

Authors:  Jennifer Norris
Journal:  Am J Lifestyle Med       Date:  2018-02-20

10.  Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial.

Authors:  Simon Stewart; Melinda J Carrington; Carla H Swemmer; Craig Anderson; Nicol P Kurstjens; John Amerena; Alex Brown; Louise M Burrell; Ferdinandus J de Looze; Mark Harris; Joseph Hung; Henry Krum; Mark Nelson; Markus Schlaich; Nigel P Stocks; Garry L Jennings
Journal:  BMJ       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.